A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

Panakeia (“the Company”), a pioneer in AI-driven multi-omic biomarker profiling, today announces the launch of PANProfiler Colon, an AI-driven software solution for profiling of Microsatellite ...

Lynch syndrome, a genetic condition caused by germline mutations in DNA mismatch repair genes, significantly increases cancer ...

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samplesEntirely digital, AI-driven molecular profiling tool for ...

When gut bacteria breaks down plant fiber, they produce two compounds that act on genes to help prevent the growth of cancers ...

NEW YORK (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S ...

For every 300 mg of daily calcium intake, the risk of CRC decreased by 17%, the strongest inverse association identified ...

Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international ...

Major advances in the field of molecular genetics, especially following completion of the human genome, expanded our ability to identify genetic events that underlie the pathogenesis of diseases ...

ETBX-051 + ETBX-061 + ETBX-011 is under clinical development by ImmunityBio and currently in Phase II for Hereditary Nonpolyposis Colon Cancer. According to GlobalData, Phase II drugs for Hereditary ...

Myriad Genetics, Inc. announced that its MyRisk® Hereditary Cancer Test with RiskScore® was recognized in the American Journal of Human Genetics as one of the top 10 significant advances in ...